« poprzedni post | następny post » |
Path: news-archive.icm.edu.pl!news.icm.edu.pl!newsfeed.pionier.net.pl!3.eu.feeder.erj e.net!feeder.erje.net!weretis.net!feeder8.news.weretis.net!newsreader4.netcolog ne.de!news.netcologne.de!peer03.ams1!peer.ams1.xlned.com!news.xlned.com!peer01. ams4!peer.am4.highwinds-media.com!news.highwinds-media.com!newsfeed.neostrada.p l!unt-exc-02.news.neostrada.pl!unt-spo-a-02.news.neostrada.pl!news.neostrada.pl .POSTED!not-for-mail Subject: Re: losartanum + indapamidum Newsgroups: pl.sci.medycyna References: <61771363$0$519$65785112@news.neostrada.pl> <X...@1...0.0.1> <6177f229$0$533$65785112@news.neostrada.pl> <X...@1...0.0.1> From: Henryk Hajdan <g...@r...com> Date: Tue, 26 Oct 2021 22:26:03 +0200 User-Agent: Mozilla/5.0 (Windows NT 10.0; Win64; x64; rv:78.0) Gecko/20100101 Thunderbird/78.14.0 MIME-Version: 1.0 In-Reply-To: <X...@1...0.0.1> Content-Type: text/plain; charset=iso-8859-2; format=flowed Content-Language: pl Content-Transfer-Encoding: 8bit Lines: 29 Message-ID: <6178645b$0$551$65785112@news.neostrada.pl> Organization: Telekomunikacja Polska NNTP-Posting-Host: 37.28.159.232 X-Trace: 1635279963 unt-rea-a-02.news.neostrada.pl 551 37.28.159.232:53709 X-Complaints-To: a...@n...neostrada.pl X-Received-Bytes: 1964 Xref: news-archive.icm.edu.pl pl.sci.medycyna:273050 Ukryj nagłówki W dniu 2021.10.26 o 20:52, PiteR pisze: |
Zobacz także